French CDMO Novasep is collaborating with compatriot biotech McSAF on the preclinical production of Adcitmer, a next-generation antibody drug conjugate (ADC) for treating...
US healthcare company Baxter International is planning to spend roughly $100 million to expand a sterile fill & finish facility at Halle in the German state of North...
The European Medicines Agency (EMA) has begun evaluating a formal application from US biotech Novavax for conditional marketing authorization of the company’s Covid-19...
An unusually acrimonious dispute has arisen over patents – in particular for Covid-19 vaccines – in the US. The row between vaccine maker Moderna and its mentor, the US...
MilliporeSigma, part of the German Merck group, has agreed to provide CDMO services for SaudiVax. The Merck offshoot will design a multi-modality manufacturing plant for...
The UK has “pipped the US at the post”, as one commentator noted in typical British colloquialism on the news that the country’s health regulator MHRA has approved the...
Swiss CDMO Lonza is making major strides to expand its position in exosome manufacturing. This week it announced two new moves. In the first, it will acquire and operate...
US food and nutrition group ADM has taken an equity stake in Slovenian biotech Acies Bio. Financial terms and the size of the stake were not disclosed.
Novavax has completed the submission of real time data to the UK’s Medicines and Health Regulatory Authority for the authorization of its Covid-19 vaccine candidate. It...
Diverse developments taking place simultaneously in Covid-19 vaccines and treatments, especially in the US, are making it difficult for the average market watcher – and...
